Speaker: Donald Yance. Part 2 continues describing targeted molecular pathways in cancer, such as EGFR, HER2/neu, and the newly discovered immune checkpoint inhibitors. Discussion covers common drugs used to block these pathways, botanicals that target certain intracellular receptors, and the important synergistic role of specific botanical, nutritional, and dietary medicines that, when combined with conventional therapies, work to enhance treatment effectiveness, inhibit tumor resistance, and reduce side effects.
Discussion also includes molecular biomarkers for assessing patient response to these targeting agents in order to determine who may benefit from which drugs. Case studies provide clinical insights and illustrate an integrative approach. 16SW02
Learn about the available CME credits for Naturopathic Doctors (ND).